{
 "url": "https://etfiq.com/funds/ftxh/holdings/",
 "section": "funds",
 "title": "FTXH Holdings: All 50 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 50 FTXH holdings with weights, as of Oct 13, 2026. The top 3 are ABBV 7.85%, LLY 7.40% and PFE 7.32%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "FTXH",
 "fund": "First Trust Nasdaq Pharmaceuticals ETF",
 "fund_page": "https://etfiq.com/funds/ftxh",
 "positions": 50,
 "positions_listed_on_page": 50,
 "lead": "FTXH held 50 positions as of Oct 13, 2026. AbbVie Inc. is the largest at 7.85%; the top 10 are 55.0% of the fund.",
 "source": {
  "name": "First Trust",
  "url": "https://www.ftportfolios.com/Retail/Etf/EtfHoldings.aspx?Ticker=FTXH",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "AbbVie Inc.",
   "ticker": "ABBV",
   "weight_pct": 7.85,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 2,
   "holding": "Eli Lilly and Company",
   "ticker": "LLY",
   "weight_pct": 7.4,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 3,
   "holding": "Pfizer Inc.",
   "ticker": "PFE",
   "weight_pct": 7.32,
   "page": "https://etfiq.com/holdings/pfe/"
  },
  {
   "rank": 4,
   "holding": "Merck & Co., Inc.",
   "ticker": "MRK",
   "weight_pct": 7.05,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 5,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 6.86,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 6,
   "holding": "Biogen Inc.",
   "ticker": "BIIB",
   "weight_pct": 3.88,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 7,
   "holding": "Viatris Inc.",
   "ticker": "VTRS",
   "weight_pct": 3.83,
   "page": "https://etfiq.com/holdings/vtrs/"
  },
  {
   "rank": 8,
   "holding": "Gilead Sciences, Inc.",
   "ticker": "GILD",
   "weight_pct": 3.71,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 9,
   "holding": "Zoetis Inc.",
   "ticker": "ZTS",
   "weight_pct": 3.54,
   "page": "https://etfiq.com/holdings/zts/"
  },
  {
   "rank": 10,
   "holding": "Amgen Inc.",
   "ticker": "AMGN",
   "weight_pct": 3.52,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 11,
   "holding": "United Therapeutics Corporation",
   "ticker": "UTHR",
   "weight_pct": 3.47,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 12,
   "holding": "Regeneron Pharmaceuticals, Inc.",
   "ticker": "REGN",
   "weight_pct": 3.46,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 13,
   "holding": "Vertex Pharmaceuticals Incorporated",
   "ticker": "VRTX",
   "weight_pct": 3.27,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 14,
   "holding": "Incyte Corporation",
   "ticker": "INCY",
   "weight_pct": 3.2,
   "page": "https://etfiq.com/holdings/incy/"
  },
  {
   "rank": 15,
   "holding": "Bristol-Myers Squibb Company",
   "ticker": "BMY",
   "weight_pct": 3.11,
   "page": "https://etfiq.com/holdings/bmy/"
  },
  {
   "rank": 16,
   "holding": "Jazz Pharmaceuticals Plc",
   "ticker": "JAZZ",
   "weight_pct": 2.45,
   "page": "https://etfiq.com/holdings/jazz/"
  },
  {
   "rank": 17,
   "holding": "Exelixis, Inc.",
   "ticker": "EXEL",
   "weight_pct": 2.43,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 18,
   "holding": "Illumina, Inc.",
   "ticker": "ILMN",
   "weight_pct": 2.3,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 19,
   "holding": "Halozyme Therapeutics, Inc.",
   "ticker": "HALO",
   "weight_pct": 1.62,
   "page": "https://etfiq.com/holdings/halo/"
  },
  {
   "rank": 20,
   "holding": "Medpace Holdings, Inc.",
   "ticker": "MEDP",
   "weight_pct": 1.54,
   "page": "https://etfiq.com/holdings/medp/"
  },
  {
   "rank": 21,
   "holding": "Alnylam Pharmaceuticals, Inc.",
   "ticker": "ALNY",
   "weight_pct": 1.18,
   "page": "https://etfiq.com/holdings/alny/"
  },
  {
   "rank": 22,
   "holding": "Elanco Animal Health Incorporated",
   "ticker": "ELAN",
   "weight_pct": 1.18,
   "page": "https://etfiq.com/holdings/elan/"
  },
  {
   "rank": 23,
   "holding": "BioMarin Pharmaceutical Inc.",
   "ticker": "BMRN",
   "weight_pct": 1.17,
   "page": "https://etfiq.com/holdings/bmrn/"
  },
  {
   "rank": 24,
   "holding": "Neurocrine Biosciences, Inc.",
   "ticker": "NBIX",
   "weight_pct": 1.17,
   "page": "https://etfiq.com/holdings/nbix/"
  },
  {
   "rank": 25,
   "holding": "Charles River Laboratories International, Inc.",
   "ticker": "CRL",
   "weight_pct": 1.06,
   "page": "https://etfiq.com/holdings/crl/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "US Dollar",
   "weight_pct": 0.1
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.02
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/ftxh/holdings/ftxh-holdings.csv",
 "json_book": "https://etfiq.com/data/books/ftxh.json",
 "markdown": "https://etfiq.com/funds/ftxh/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of FTXH, data as of Oct 13, 2026. https://etfiq.com/funds/ftxh/holdings/"
}